liu.seSearch for publications in DiVA
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Commentary: Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass. The Annals of Thoracic Surgery, Volume 77, Issue 3, March 2004, Pages 942-949: Invited commentary
Department of Cardiothoracic Surgery, University Hospital, Linkoping, SE-581 85, Sweden.
2004 (engelsk)Inngår i: Annals of Thoracic Surgery, ISSN 0003-4975, E-ISSN 1552-6259, Vol. 77, nr 3, s. 949-950s. 949-950Artikkel i tidsskrift, Editorial material (Annet vitenskapelig) Published
Abstract [en]

[No abstract available]

sted, utgiver, år, opplag, sider
2004. Vol. 77, nr 3, s. 949-950s. 949-950
Emneord [en]
25
HSV kategori
Identifikatorer
URN: urn:nbn:se:liu:diva-45815DOI: 10.1016/j.athoracsur.2003.10.023OAI: oai:DiVA.org:liu-45815DiVA, id: diva2:266711
Tilgjengelig fra: 2009-10-11 Laget: 2009-10-11 Sist oppdatert: 2017-12-13bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekst
I samme tidsskrift
Annals of Thoracic Surgery

Søk utenfor DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric

doi
urn-nbn
Totalt: 53 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf